Glenmark Pharmaceuticals plans to raise Rs 945 crIllustrative image – not actual.

Glenmark Pharmaceuticals plans to raise approximately Rs 945 crore by issuing one crore shares to Temasek Holdings, the investment arm of the Singapore government.


During its board meeting on 17 April, Glenmark decided to raise funds by issuing upto 1.08 crore shares of Rs one each for cash to Aranda Investments (Mauritius) on a preferential basis, at a price of Rs 875 per equity share.


Mauritius-based Aranda is a foreign portfolio investor and a wholly-owned indirect subsidiary of Temasek Holdings, the investment arm of the Singapore government.


Glenmark employs over 10,400 people in more than 80 countries. It has 14 manufacturing facilities in four countries and has six R&D centres.


 

← All latest storiesBack to top →